뉴스
- i-SENS Soars on Earnings, Peptron Rebounds, Cellid Hits Limit-Up[K-Bio Pulse] South Korean pharmaceutical and biotechnology stocks were mixed Monday, with i-SENS soaring after reporting second quarter earnings that far exceeded market exp
- InBody Rallies on GLP-1 Buzz, Cellid Sinks[K-Bio Pulse] Shares of South Korean biotech companies moved sharply in different directions on Monday as company-specific developments drove investor sentiment. InBody exten
- Cellid Crashes After-Hours on Phase 3 Failure...Shaperon Dives 25%[K-bio pulse] In the biopharmaceutical sector on Friday, Cellid’s stock surged on expectations for its vaccine
- [K-Bio Pulse]Biotech Stocks Defy 'Black Tuesday' as MedPacto Soars, Bioinfra Faces Dead... As the Kosdaq tumbled, Cellid, Bioinfra, and MedPacto all hit the daily upper limit.